Balazs B Lörincz1, Nikolaus Möckelmann1, Chia-Jung Busch1, Rainald Knecht1. 1. Department of Otorhinolaryngology, Head and Neck Surgery and Oncology, Head and Neck Cancer Centre of the Hubertus Wald University Cancer Centre Hamburg, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Abstract
BACKGROUND: This is a single-institution prospective study in a tertiary care center to evaluate feasibility, completeness of resection, and functional outcomes for oropharyngeal squamous cell carcinoma (SCC) treated primarily with transoral robotic-assisted resection. METHODS: Thirty-five patients with T1 and T2 squamous cell carcinoma of the oropharynx were included. They underwent transoral robotic surgery (TORS) between September 2011 and April 2013, with a median follow-up time of 13 months. RESULTS: Main outcome measures were completeness of resection, disease-free survival, and cancer recurrence for the preliminary oncologic outcome; postoperative bleeding, number of days intubated, rate of elective tracheotomy, duration of intensive care and/or intermediate care, speech and swallowing function, and length of nasogastric and/or gastrostomy tube dependency for the functional results. CONCLUSION: Our 1-year (median) functional and early oncologic results of 35 patients with oropharyngeal cancer treated primarily with TORS are encouraging to continue gaining further experiences with this surgical modality on a select subgroup of patients.
BACKGROUND: This is a single-institution prospective study in a tertiary care center to evaluate feasibility, completeness of resection, and functional outcomes for oropharyngeal squamous cell carcinoma (SCC) treated primarily with transoral robotic-assisted resection. METHODS: Thirty-five patients with T1 and T2 squamous cell carcinoma of the oropharynx were included. They underwent transoral robotic surgery (TORS) between September 2011 and April 2013, with a median follow-up time of 13 months. RESULTS: Main outcome measures were completeness of resection, disease-free survival, and cancer recurrence for the preliminary oncologic outcome; postoperative bleeding, number of days intubated, rate of elective tracheotomy, duration of intensive care and/or intermediate care, speech and swallowing function, and length of nasogastric and/or gastrostomy tube dependency for the functional results. CONCLUSION: Our 1-year (median) functional and early oncologic results of 35 patients with oropharyngeal cancer treated primarily with TORS are encouraging to continue gaining further experiences with this surgical modality on a select subgroup of patients.
Authors: Axel Sahovaler; David E Eibling; Ida Bruni; Uma Duvvuri; S Danielle MacNeil; Anthony C Nichols; John Yoo; Kevin Fung; Kathryn Roth Journal: J Robot Surg Date: 2019-01-23
Authors: Mark Kubik; Rajarsi Mandal; William Albergotti; Umamaheswar Duvvuri; Robert L Ferris; Seungwon Kim Journal: Head Neck Date: 2017-06-01 Impact factor: 3.147
Authors: Emma Keane; Isobel O'Riordan; Thomas Crotty; Justin M Hintze; Edlir Shytaj; Fergal O'Duffy; Tadgh P O'Dwyer; Tom Moran Journal: Ir J Med Sci Date: 2021-02-09 Impact factor: 1.568
Authors: Andrew J Holcomb; Matthew Herberg; Madeleine Strohl; Edgar Ochoa; Allen L Feng; Nicholas B Abt; Tara E Mokhtari; Krish Suresh; Christopher I McHugh; Anuraag S Parikh; Peter Sadow; William Faquin; Daniel Faden; Daniel G Deschler; Mark A Varvares; Derrick T Lin; Carole Fakhry; William R Ryan; Jeremy D Richmon Journal: Head Neck Date: 2021-04-15 Impact factor: 3.821
Authors: Lara Bußmann; Simon Laban; Claus Wittekindt; Carmen Stromberger; Silke Tribius; Nikolaus Möckelmann; Arne Böttcher; Christian Stephan Betz; Jens Peter Klussmann; Volker Budach; Adrian Muenscher; Chia-Jung Busch Journal: BMC Cancer Date: 2020-07-29 Impact factor: 4.430
Authors: Yun Hee Lee; Yeon Sil Kim; Mi Joo Chung; Mina Yu; So Lyung Jung; Ie Ryung Yoo; Youn Soo Lee; Min Sik Kim; Dong Il Sun; Jin Hyung Kang Journal: Medicine (Baltimore) Date: 2016-03 Impact factor: 1.889